Process View
Any process that modulates the frequency, rate or extent of focal adhesion formation, the establishment and maturation of focal adhesions.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of focal adhesion assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.999 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.998 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.990 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.971 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.911 | ||
| NRP1 | neuropilin 1 | 0.898 | ||
| S100A6 | S100 calcium binding protein A6 | 0.897 | Human | |
| S100A8 | S100 calcium binding protein A8 | 0.887 | Human | |
| S100B | S100 calcium binding protein B | 0.876 | Human | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.857 | ||
| S100A9 | S100 calcium binding protein A9 | 0.808 | Human | |
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.699 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.692 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.658 | Human | |
| ENG | endoglin | 0.581 | ||
| SMAD2 | SMAD family member 2 | 0.541 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.485 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.470 | ||
| FHL2 | four and a half LIM domains 2 | 0.467 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.457 | ||
| S100A11 | S100 calcium binding protein A11 | 0.448 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.426 | ||
| NCK2 | NCK adaptor protein 2 | 0.426 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.415 | Human | |
| ANXA2 | annexin A2 | 0.396 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.395 | ||
| BMP2 | bone morphogenetic protein 2 | 0.335 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.322 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.321 | ||
| EPHA7 | EPH receptor A7 | 0.312 | Human | |
| ANGPT2 | angiopoietin 2 | 0.295 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.288 | ||
| S100A1 | S100 calcium binding protein A1 | 0.275 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.269 | ||
| EPHA2 | EPH receptor A2 | 0.265 | Human | |
| EFNA1 | ephrin-A1 | 0.257 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.241 | ||
| RHOA | ras homolog gene family, member A | 0.223 | ||
| SMAD7 | SMAD family member 7 | 0.208 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.196 | Human | |
| LPXN | leupaxin | 0.166 | Human | |
| PGF | placental growth factor | 0.165 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.162 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.144 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.135 | ||
| TSC2 | tuberous sclerosis 2 | 0.126 | ||
| GDF5 | growth differentiation factor 5 | 0.121 | ||
| EGFR | epidermal growth factor receptor | 0.118 | ||
| ACVR1 | activin A receptor, type I | 0.116 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.109 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.106 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.095 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.085 | Human | |
| GRB7 | growth factor receptor-bound protein 7 | 0.075 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.066 | Human | |
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.065 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.062 | ||
| AREG | amphiregulin | 0.062 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.059 | Human | |
| TSG101 | tumor susceptibility gene 101 | 0.058 | ||
| PDGFC | platelet derived growth factor C | 0.057 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.056 | ||
| ZNF746 | zinc finger protein 746 | 0.052 | ||
| ANGPT1 | angiopoietin 1 | 0.051 | ||
| AHNAK | AHNAK nucleoprotein | 0.051 | ||
| CD63 | CD63 molecule | 0.050 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.047 | ||
| S100A2 | S100 calcium binding protein A2 | 0.045 | Human | |
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.045 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.043 | ||
| GHR | growth hormone receptor | 0.042 | ||
| TMSB10 | thymosin beta 10 | 0.041 | ||
| KITLG | KIT ligand | 0.041 | ||
| EFNA5 | ephrin-A5 | 0.039 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.038 | ||
| FN1 | fibronectin 1 | 0.038 | ||
| EZR | ezrin | 0.038 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.036 | ||
| EMP3 | epithelial membrane protein 3 | 0.036 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.035 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.034 | ||
| BMP4 | bone morphogenetic protein 4 | 0.034 | ||
| S100A4 | S100 calcium binding protein A4 | 0.034 | Human | |
| ILK | integrin-linked kinase | 0.033 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.033 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.032 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.032 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.031 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.030 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.030 | ||
| GORAB | golgin, RAB6-interacting | 0.029 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.029 | Human | |
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.029 | ||
| JAG1 | jagged 1 | 0.028 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.028 | ||
| HOXA1 | homeobox A1 | 0.028 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.026 | ||
| ANXA5 | annexin A5 | 0.026 | ||
| SLA | Src-like-adaptor | 0.025 | ||
| LIMK1 | LIM domain kinase 1 | 0.025 | ||
| LDLR | low density lipoprotein receptor | 0.025 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.024 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.024 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.023 | Human | |
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.023 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.022 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.022 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.022 | Human | |
| SKIL | SKI-like oncogene | 0.021 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.021 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.020 | ||
| ANXA1 | annexin A1 | 0.020 | ||
| EFNB2 | ephrin-B2 | 0.020 | Human | |
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.020 | ||
| LMNA | lamin A/C | 0.019 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.019 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.018 | ||
| ITGA6 | integrin, alpha 6 | 0.018 | ||
| ITGA7 | integrin, alpha 7 | 0.018 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.017 | ||
| S100A12 | S100 calcium binding protein A12 | 0.017 | Human | |
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.017 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.017 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.017 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.017 | ||
| NRP2 | neuropilin 2 | 0.016 | ||
| VCL | vinculin | 0.016 | ||
| TAGLN2 | transgelin 2 | 0.016 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.015 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.015 | ||
| SFN | stratifin | 0.015 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.015 | ||
| JUP | junction plakoglobin | 0.015 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.015 | Human | |
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.015 | ||
| MSN | moesin | 0.014 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.014 | ||
| BMP1 | bone morphogenetic protein 1 | 0.014 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.014 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.014 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.014 | ||
| S100A10 | S100 calcium binding protein A10 | 0.014 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.013 | ||
| TSPO | translocator protein (18kDa) | 0.013 | ||
| EPHB3 | EPH receptor B3 | 0.013 | Human | |
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.013 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.013 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.013 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.012 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.012 | ||
| LAT | linker for activation of T cells | 0.012 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.012 | ||
| CD9 | CD9 molecule | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| CSTA | cystatin A (stefin A) | 0.012 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.012 | ||
| AR | androgen receptor | 0.012 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.012 | ||
| EPHA3 | EPH receptor A3 | 0.012 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.012 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.012 | ||
| APC | adenomatous polyposis coli | 0.012 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.011 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.011 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.011 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.011 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.011 | ||
| RHOU | ras homolog gene family, member U | 0.011 | ||
| PTEN | phosphatase and tensin homolog | 0.010 | ||
| PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) | 0.010 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.010 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.010 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.010 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.010 |